Barry E Greene - Net Worth and Insider Trading
Barry E Greene Net Worth
The estimated net worth of Barry E Greene is at least $11 Million dollars as of 2024-05-16. Barry E Greene is the President of Alnylam Pharmaceuticals Inc and owns about 73,501 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $11 Million. Barry E Greene is the President and CEO of Sage Therapeutics Inc and owns about 46,940 shares of Sage Therapeutics Inc (SAGE) stock worth over $549,667. Barry E Greene is also the Director of Karyopharm Therapeutics Inc and owns about 3,000 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $3,390. Besides these, Barry E Greene also holds Acorda Therapeutics Inc (ACORQ) . Details can be seen in Barry E Greene's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barry E Greene has not made any transactions after 2022-11-10 and currently still holds the listed stock(s).
Transaction Summary of Barry E Greene
Barry E Greene Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry E Greene owns 6 companies in total, including BCLS Acquisition Corp (BLSA) , Sage Therapeutics Inc (SAGE) , and Alnylam Pharmaceuticals Inc (ALNY) among others .
Click here to see the complete history of Barry E Greene’s form 4 insider trades.
Insider Ownership Summary of Barry E Greene
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLSA | BCLS Acquisition Corp | 2020-10-22 | director |
| SAGE | Sage Therapeutics Inc | 2022-11-10 | director |
| ALNY | Alnylam Pharmaceuticals Inc | 2020-09-09 | COO and Treasurer |
 | | 2017-08-01 | director |
| | 2015-04-02 | director |
| | 2012-10-04 | director & 10 percent owner |
Barry E Greene Latest Holdings Summary
Barry E Greene currently owns a total of 4 stocks. Among these stocks, Barry E Greene owns 73,501 shares of Alnylam Pharmaceuticals Inc (ALNY) as of September 9, 2020, with a value of $11 Million and a weighting of 95.14%. Barry E Greene owns 46,940 shares of Sage Therapeutics Inc (SAGE) as of November 10, 2022, with a value of $549,667 and a weighting of 4.83%. Barry E Greene also owns 3,000 shares of Karyopharm Therapeutics Inc (KPTI) as of April 2, 2015, with a value of $3,390 and a weighting of 0.03%. The other 1 stocks Acorda Therapeutics Inc (ACORQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Barry E Greene
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2020-09-09 | 73,501 | 147.40 | 10,834,047 |
| SAGE | Sage Therapeutics Inc | 2022-11-10 | 46,940 | 11.71 | 549,667 |
| KPTI | Karyopharm Therapeutics Inc | 2015-04-02 | 3,000 | 1.13 | 3,390 |
| ACORQ | Acorda Therapeutics Inc | 2017-08-01 | 0 | 0.64 | 0 |
Holding Weightings of Barry E Greene
Barry E Greene Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry E Greene has made a total of 4 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 44,530 shares on September 9, 2020, which brought Barry E Greene around $5 Million.
According to the SEC Form 4 filings, Barry E Greene has made a total of 2 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 14,500 shares on November 10, 2022, which cost Barry E Greene around $499,960.
According to the SEC Form 4 filings, Barry E Greene has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the acquisition of 3,000 shares on April 2, 2015, which cost Barry E Greene around $87,930.
More details on Barry E Greene's insider transactions can be found in the Insider Trading History of Barry E Greene table.Insider Trading History of Barry E Greene
- 1
Barry E Greene Trading Performance
GuruFocus tracks the stock performance after each of Barry E Greene's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barry E Greene is 21.97%. GuruFocus also compares Barry E Greene's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barry E Greene within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barry E Greene's insider trading performs compared to the benchmark.
Performance of Barry E Greene
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.95 | | | | | |
| Relative Return to S&P 500(%) | 11.49 | | | | | |
Barry E Greene Ownership Network
Barry E Greene Owned Company Details
What does BCLS Acquisition Corp do?
Who are the key executives at BCLS Acquisition Corp?
Barry E Greene is the director of BCLS Acquisition Corp. Other key executives at BCLS Acquisition Corp include director & 10 percent owner Adam Koppel , director & 10 percent owner & Chief Executive Officer Jeffrey Lawrence Schwartz , and director & 10 percent owner & Chief Financial Officer Hack Andrew A. F. .
BCLS Acquisition Corp (BLSA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BCLS Acquisition Corp (BLSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BCLS Acquisition Corp (BLSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BCLS Acquisition Corp (BLSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
BCLS Acquisition Corp Insider Transactions
Barry E Greene Mailing Address
Above is the net worth, insider trading, and ownership report for Barry E Greene. You might contact Barry E Greene via mailing address: C/o Acorda Therapeutics, 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
